J&J Wins Jury Verdict Against Boston Scientific In Stents Patent Battle
On Tuesday, the Delaware jury found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare-metal stents infringed J&J's core Palmaz patent for balloon expandable stents.
The jury also found the Liberte stent infringed another patent, called the Gray patent, that covers flexible stent technology and expires in 2016.
Boston Scientific had challenged the validity of...
To view the full article, register now.